SFN has previously been shown to have anti-proliferative effects against breast cancer via increased expression of p53, p21, and the phosphatase and tensin homolog (PTEN), which was associated with epigenetic modulation of DNMT1. The gene discussed is CDKN1A; the disease is breast carcinoma.